Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 3137 - 3144 of 12004 results

Don’t Be Caught Without Possession (of Your Invention): What You Need To Know About the Written Description Requirement

May 12, 2021| News

Revisions to National Interest Exceptions to Schengen Travel Ban

May 12, 2021| Alert| Viewpoint

Health Law Diagnosed — Hot Topics in FDA Regulation and Enforcement

May 12, 2021| Podcast| Viewpoint

Massachusetts Public Health Council Approves Amendments to Clinic Licensure Regulations

May 11, 2021| Blog| Viewpoint

The American Families Plan & A Call for Drug Pricing Legislation

May 10, 2021| Blog| Viewpoint

With OSHA Slow on Guidance, Companies, Law Firms Are Slow to Return to Offices

May 7, 2021| News

FDA Ups the Ante and Sends First Notice of Noncompliance for Failure to Submit Clinical Trial Results

May 6, 2021| Blog| Viewpoint

Pro Bono Attorney Keeps Single Mother and Her Kids Housed After Months of Uncertainty

May 6, 2021| News

News & Press Releases

Mintz Advises Syntis Bio on $33 Million Series A Financing

July 02, 2025

Mintz advised Syntis Bio, a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes, and rare diseases, on a $33 million oversubscribed Series A financing.

Mintz Obtains Trademark TRO Against OpenAI on Behalf of IYO, Inc.

June 30, 2025

Mintz secured a rare trademark temporary restraining order (TRO) on behalf of IYO, Inc. against OpenAI, Sam Altman, Sir Jony Ive, and IO Products, Inc. The order temporarily bars the defendants from using the trademark associated with their new product launch.

Mintz Advises Brij in $8M Oversubscribed Funding Round

June 26, 2025

Mintz advised Brij—a software platform enhancing the consumer experience by bridging online and offline commerce—on the closing of its $8 million Series Seed round. The funding will help Brij advance its mission to close the trillion-dollar disconnect between brands and their retail customers and power the next generation of offline-to-online customer relationships.

View all News and Press Releases